NCT06644144
P4O2 ILD Extension No drug interventions Not Available Not Available not_yet_recruiting NCT06372353
The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT06636487
Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD No drug interventions health_services_research Not Available not_yet_recruiting NCT05938920
Study Evaluating INS018_055 Administered Orally to Subjects with Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT01718990
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT05387785
Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 unknown_status NCT05361733
A First-in-human Study of the Safety, Tolerability, and PK of XFB-19 in Healthy Adult Volunteers No drug interventions treatment 1 unknown_status NCT04598919
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 / 2 active_not_recruiting NCT02538536
A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT02013700
Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) treatment 1 terminated NCT01776398
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies No drug interventions Not Available Not Available recruiting NCT01371305
STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT03619616
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults No drug interventions treatment 1 completed NCT05975983
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis treatment 2 recruiting NCT05119972
Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） No drug interventions treatment 1 / 2 recruiting NCT03981094
A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants treatment 1 completed NCT03832946
A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT03720483
Inhaled NAC in Treatment of IPF No drug interventions treatment 1 / 2 withdrawn NCT03650075
To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers treatment 1 completed NCT03478553
The Genetics of Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT02758808
Pulmonary Fibrosis Foundation Patient Registry No drug interventions Not Available Not Available completed NCT00162760
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide treatment 2 completed NCT04589260
TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 terminated NCT04497831
Morphine for Dyspnea in Pulmonary Fibrosis treatment 3 unknown_status NCT04069143
A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 No drug interventions diagnostic 1 completed NCT03050255
Short-term Effects of Supplemental Oxygen in Patients With IPF No drug interventions treatment Not Available completed NCT02874989
Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial basic_science 1 completed NCT06650774
Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT06588686
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. treatment 2 recruiting NCT05785624
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease treatment 2 recruiting NCT05964335
Cough Reduction in IPF with Nalbuphine ER treatment 2 recruiting NCT05988463
Open-Label Dose-Escalation Treatment Study of Patients with IPF treatment 1 not_yet_recruiting NCT06003426
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis treatment 3 recruiting NCT06097260
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis treatment 2 recruiting NCT06238622
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550 treatment 3 recruiting NCT06325696
H01 in Adults With Interstitial Lung Disease (The SOLIS Study) treatment 2 not_yet_recruiting NCT06335303
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 recruiting NCT06360094
A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis No drug interventions treatment 2 recruiting NCT06629623
Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available enrolling_by_invitation NCT04905693
Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis treatment 3 enrolling_by_invitation NCT05255991
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis treatment 3 active_not_recruiting NCT05382572
Pulmonary Fibrosis Foundation Community Registry No drug interventions Not Available Not Available recruiting NCT05392881
Interstitial Lung Disease Research Unit Biobank No drug interventions Not Available Not Available recruiting NCT05497284
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF No drug interventions treatment 2 terminated NCT05671835
Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis treatment 2 recruiting NCT04071769
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis diagnostic 2 active_not_recruiting NCT05870956
Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients Not Available Not Available completed NCT06625489
A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib treatment 1 not_yet_recruiting NCT05321069
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 active_not_recruiting NCT05483907
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients with IPF treatment 2 active_not_recruiting NCT06132256
Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 recruiting NCT06317285
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 recruiting NCT06485635
Real-life-persistence to Antifibrotic Treatments Not Available Not Available not_yet_recruiting NCT06588517
Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions basic_science 1 completed NCT06589921
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions basic_science 1 completed NCT00391443
BUILD 3: Bosentan Use in Interstitial Lung Disease treatment 3 completed NCT04031690
Health and Quality of Life Assessment Project for Caregivers of Idiopathic Pulmonary Fibrosis Patients No drug interventions Not Available Not Available completed NCT02248064
Auto-titrating Oxygen in Chronic Respiratory Failure No drug interventions other Not Available completed NCT01118221
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients No drug interventions treatment Not Available completed NCT05468502
Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 1 recruiting NCT03502902
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects No drug interventions treatment 1 completed NCT05657184
Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001 No drug interventions treatment 1 completed NCT03898284
Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT06422884
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) treatment 2 not_yet_recruiting NCT04187079
Immunopathologic Profiles and Blood Biomarkers in Patients With IPF No drug interventions Not Available Not Available completed NCT03229343
Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis. No drug interventions supportive_care Not Available unknown_status NCT02141087
Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone Not Available Not Available approved_for_marketing NCT01214187
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis treatment 2 completed NCT05424887
A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment 2 not_yet_recruiting NCT05366387
Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available recruiting NCT00705133
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension treatment 2 completed NCT03208933
Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF). treatment 3 completed NCT04177251
Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT04931147
A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers No drug interventions treatment 1 completed NCT03928847
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. other 0 completed NCT03215147
Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available unknown_status NCT03770845
Nutritional Assessment in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT01499745
Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients No drug interventions treatment Not Available unknown_status NCT01154998
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions. No drug interventions Not Available Not Available unknown_status NCT03744598
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available terminated NCT05989698
C-mo System 1.0's Validation - Cough Monitoring No drug interventions other Not Available recruiting NCT00074698
Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis treatment 1 completed NCT02397005
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects No drug interventions treatment 1 unknown_status NCT02052297
A Validation and Dosimetry Study of GSK2634673F PET Ligand No drug interventions basic_science 1 terminated NCT02502097
A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) treatment 2 completed NCT06102083
A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment 2 not_yet_recruiting NCT00105183
EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection No drug interventions prevention 3 completed NCT00463983
Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide treatment 1 / 2 completed NCT03300583
Toward Self-management in ILD No drug interventions Not Available Not Available completed NCT01457261
IPF Drug Deposition Study treatment 1 completed NCT02885961
The Coagulation Cascade in Idiopathic Pulmonary Fibrosis basic_science Not Available unknown_status NCT00600028
Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide treatment 3 completed NCT00815711
Idiopathic Pulmonary Fibrosis Registry for Future Studies No drug interventions Not Available Not Available completed NCT02598193
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 4 completed NCT02187393
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available withdrawn NCT04572971
Reliability and Validity of iOS in IPF No drug interventions Not Available Not Available completed NCT05022771
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 No drug interventions treatment 1 completed NCT03503188
Digital Auscultation Test - IPF Data Collection No drug interventions treatment 4 completed NCT05954988
A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients other 1 recruiting NCT02460588
Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis treatment 3 completed NCT05784207
An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors No drug interventions Not Available Not Available completed NCT03211507
Idiopathic Pulmonary Fibrosis Job Exposures Study No drug interventions Not Available Not Available completed NCT01071707
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions Not Available Not Available completed NCT02176707
Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available unknown_status NCT02477709
A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT01254409
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 1 completed NCT01366209
Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 completed NCT02055456
Nandrolone Decanoate in the Treatment of Telomeropathies treatment 1 / 2 completed NCT04396756
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis treatment 2 completed NCT00125385
Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 1 completed NCT01619085
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis treatment 3 completed NCT03268915
Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test No drug interventions diagnostic Not Available completed NCT04888715
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers treatment 1 completed NCT04072315
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ treatment 2 completed NCT04160715
Korean Idiopathic Pulmonary Fibrosis Registry No drug interventions Not Available Not Available recruiting NCT03261037
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period No drug interventions other Not Available completed NCT03360032
Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF No drug interventions Not Available Not Available unknown_status NCT03725852
A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT04693975
Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases No drug interventions Not Available Not Available unknown_status NCT00631475
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 treatment 3 completed NCT04838275
IPF mHealth Exercise No drug interventions treatment Not Available recruiting NCT04540770
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 No drug interventions treatment 1 recruiting NCT03171870
Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis No drug interventions diagnostic Not Available unknown_status NCT02345070
Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis treatment 2 completed NCT05130970
CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis treatment 2 completed NCT04619199
Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis No drug interventions other Not Available recruiting NCT04552899
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis treatment 3 terminated NCT04419506
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT03981406
Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT01462006
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) treatment Not Available completed NCT02552849
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada No drug interventions Not Available Not Available completed NCT02530736
Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT00453713
Race, Ethnicity, and Diffuse Parenchymal Lung Disease No drug interventions Not Available Not Available completed NCT03115619
Quality of Life Study in Participants With IPF Under Pirfenidone Treatment Not Available Not Available completed NCT02019641
The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease No drug interventions supportive_care Not Available completed NCT02755441
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF No drug interventions Not Available Not Available active_not_recruiting NCT05016817
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF No drug interventions treatment 1 recruiting NCT06567717
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis treatment 2 not_yet_recruiting NCT01766817
Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis treatment 2 completed NCT03836417
Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study No drug interventions Not Available Not Available recruiting NCT05976217
Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis treatment 0 completed NCT05098717
End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation No drug interventions Not Available Not Available recruiting NCT02929017
Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers No drug interventions supportive_care Not Available completed NCT03666234
Idiopathic Pulmonary Fibrosis Registry China Study No drug interventions Not Available Not Available unknown_status NCT03688334
Acute Effects of Oxygen Supplementation Among IPF Patients treatment Not Available unknown_status NCT02846324
Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF supportive_care 2 completed NCT06331624
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF treatment 2 recruiting NCT03562416
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects treatment 2 terminated NCT00692796
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT01321996
68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis No drug interventions diagnostic 4 terminated NCT01769196
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 terminated NCT04572958
Changes in iOS in IPF No drug interventions Not Available Not Available active_not_recruiting NCT00076635
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF treatment 3 terminated NCT03711435
Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics No drug interventions Not Available Not Available completed NCT01266135
Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 terminated NCT03420235
Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life No drug interventions treatment Not Available completed NCT05095363
Palliative Care Planner (PCplanner) No drug interventions supportive_care Not Available completed NCT03437486
Mechanisms of Familial Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT06445686
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. No drug interventions Not Available Not Available recruiting NCT02315586
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT02821039
Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study No drug interventions Not Available Not Available terminated NCT02594839
Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease No drug interventions treatment 1 / 2 completed NCT00703339
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis treatment 2 terminated NCT01134822
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England) No drug interventions Not Available Not Available completed NCT04244825
Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF treatment 2 withdrawn NCT02168530
A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) treatment 2 withdrawn NCT01346930
Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis treatment 2 withdrawn NCT02648048
A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis treatment 1 completed NCT04148157
Quality of Life in IPF - Patient and Physician Perceptions No drug interventions Not Available Not Available unknown_status NCT02503657
Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT04677426
129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study diagnostic 2 withdrawn NCT02788474
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment treatment 4 completed NCT00131274
Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study educational_counseling_training 2 / 3 completed NCT01136174
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF Not Available 2 completed NCT01809574
The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease No drug interventions Not Available Not Available unknown_status NCT06189820
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases No drug interventions diagnostic 2 recruiting NCT03761082
Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy No drug interventions Not Available Not Available completed NCT02230982
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis Not Available Not Available no_longer_available NCT01637831
CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea No drug interventions treatment Not Available completed NCT05449431
Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary Fibrosis No drug interventions other Not Available recruiting NCT02407431
PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort No drug interventions Not Available Not Available active_not_recruiting NCT03865927
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis treatment 2 recruiting NCT05515627
Atezolizumab for Idiopathic Pulmonary Fibrosis treatment 1 recruiting NCT01919827
Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 completed NCT06125327
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 / 3 recruiting NCT00470327
A Study of the Natural Progression of Interstitial Lung Disease (ILD) No drug interventions Not Available Not Available recruiting NCT06323876
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT00189176
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis treatment 1 / 2 completed NCT03670576
It's Not JUST Idiopathic Pulmonary Fibrosis Study No drug interventions Not Available Not Available unknown_status NCT03588260
Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT04312594
Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis treatment 2 active_not_recruiting NCT03386994
OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study No drug interventions Not Available Not Available completed NCT01110694
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study No drug interventions Not Available Not Available completed NCT01150591
Microaspiration in Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT03711162
A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care treatment 3 terminated NCT02135380
Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 / 2 unknown_status NCT04019080
Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden No drug interventions Not Available Not Available unknown_status NCT05331729
Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis No drug interventions diagnostic 1 recruiting NCT02951429
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension treatment 2 completed NCT05052229
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). basic_science 0 recruiting NCT00287729
Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis treatment 3 completed NCT00879229
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis treatment 3 terminated NCT03326089
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT01872689
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT02136992
Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis treatment 2 completed NCT05984992
The First-in-human Study of SRN-001 in Healthy Participants No drug interventions treatment 1 active_not_recruiting NCT03733444
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care treatment 3 terminated NCT02048644
Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis treatment 2 completed NCT05154240
A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects treatment 1 completed NCT00512967
The Occurence of Inflammation and Oxidative Stress in Lung Diseases No drug interventions Not Available Not Available completed NCT01772667
Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis No drug interventions health_services_research Not Available completed NCT01629667
A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis treatment 2 terminated NCT02738801
Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT00625469
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan treatment 4 withdrawn NCT04643769
Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 1 active_not_recruiting NCT03955146
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 terminated NCT04586946
FIBRotic Interstitial Lung Disease and Nocturnal OXygen No drug interventions Not Available Not Available completed NCT02818712
Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up No drug interventions Not Available Not Available completed NCT03717012
Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 4 terminated NCT02268981
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) No drug interventions treatment Not Available completed NCT05842681
Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis treatment Not Available not_yet_recruiting NCT06569381
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions basic_science 1 not_yet_recruiting NCT03548181
Feasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 unknown_status NCT04016181
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study No drug interventions Not Available Not Available enrolling_by_invitation NCT05373914
RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 unknown_status NCT03287414
Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis treatment 2 terminated NCT03890250
Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT02632123
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT06037408
The Effect of N115 on Coughing in IPF Patients treatment 3 completed NCT01695408
Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT06488638
Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment Not Available not_yet_recruiting NCT04720443
A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects treatment 1 completed NCT02579603
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF treatment 4 completed NCT03979703
Yoga in Patients With Fibrosing Interstitial Lung Diseases No drug interventions other Not Available completed NCT06482190
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers No drug interventions treatment 1 recruiting NCT04187690
Jin-shui Huan-xian Granule in the Treatment of IPF No drug interventions treatment Not Available unknown_status NCT05722964
Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment 2 recruiting NCT04564664
High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis treatment Not Available completed NCT06081621
A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 recruiting NCT03092102
The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects treatment 1 completed NCT03727802
Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis treatment 1 completed NCT02058602
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients No drug interventions diagnostic 1 completed NCT05022784
Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients Not Available Not Available completed NCT02745184
Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 / 2 completed NCT02699879
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Not Available Not Available completed NCT00625079
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil treatment 4 withdrawn NCT01199887
Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 completed NCT00532233
SD, IL-13 Production Rate in IPF diagnostic 2 completed NCT05113654
Sleep Disorders in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT03560154
Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease No drug interventions treatment Not Available unknown_status NCT03480451
Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis No drug interventions supportive_care Not Available terminated NCT02612051
First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients No drug interventions treatment 1 completed NCT05427253
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects No drug interventions basic_science 1 completed NCT01529853
To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 1 / 2 completed NCT02606877
A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination treatment 4 completed NCT02257177
RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients treatment 1 / 2 completed NCT02622477
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone) Not Available Not Available completed NCT04775277
Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy No drug interventions Not Available Not Available completed NCT02688647
A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis treatment 2 completed NCT04525547
Safety and Effectiveness of Nintedanib in Korean Patients Not Available Not Available completed NCT00981747
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis treatment 2 / 3 terminated NCT03562247
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions supportive_care Not Available terminated NCT02173145
Azithromycin in Idiopathic Pulmonary Fibrosis treatment Not Available completed NCT02802345
Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment treatment 3 completed NCT00047645
A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 completed NCT00075998
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) treatment 3 terminated NCT04965298
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole treatment 3 recruiting NCT00262405
Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis treatment 2 completed NCT03573505
An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis No drug interventions treatment 2 terminated NCT00203697
Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study treatment 3 unknown_status NCT06267183
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. No drug interventions treatment 0 recruiting NCT00071461
Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis treatment 2 / 3 completed NCT03944928
ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution No drug interventions Not Available Not Available completed NCT01107028
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT04888728
To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers treatment 1 completed NCT01738711
Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients No drug interventions supportive_care Not Available unknown_status NCT01759511
Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 terminated NCT04442711
Cohort of IPF Patients Experiencing an Exacerbation No drug interventions Not Available Not Available recruiting NCT00212511
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry No drug interventions Not Available Not Available withdrawn NCT06563011
The Assessment of Nutritional Status of Patients With IPF No drug interventions screening Not Available completed NCT02009293
The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT05173571
Homecare Integral Support Program for IPF Patients No drug interventions supportive_care Not Available completed NCT03958071
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking Not Available Not Available completed NCT05983471
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) treatment 2 not_yet_recruiting NCT02436278
The Predictive Ability of 4MGS in IPF No drug interventions Not Available Not Available completed NCT01265888
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. treatment 2 completed NCT05779007
Dose Reduction and Discontinuation With Anti-Fibrotic Medications Not Available Not Available completed NCT01841307
Cromolyn Detection of Silent Aspiration diagnostic 1 terminated NCT04594707
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis treatment 3 terminated NCT02171156
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP) Not Available Not Available approved_for_marketing NCT05353556
Effects of Home-based Inspiratory Muscle Training in Patients With IPF No drug interventions treatment Not Available completed NCT03567785
Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT04268485
Longitudinal Changes in Serum KL-6 in IPF No drug interventions Not Available Not Available recruiting NCT04767815
To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers No drug interventions treatment 1 completed NCT05389215
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF treatment 2 recruiting NCT01777737
Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole treatment 3 terminated NCT06265532
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect treatment 1 recruiting NCT01979952
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 completed NCT05621252
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) treatment 2 completed NCT03281200
Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain Not Available Not Available completed NCT00768300
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF treatment 3 terminated NCT05571059
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 recruiting NCT03732859
PROOF-Registry New and Extended Belgium -Luxembourg No drug interventions Not Available Not Available completed NCT04541875
Medication Adherence and Non-adherence in Adults With Rare Disease No drug interventions Not Available Not Available withdrawn NCT05241275
Xenon MRI and Progressive ILD diagnostic 2 recruiting NCT00540475
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry No drug interventions Not Available Not Available completed NCT03499275
Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT04512170
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects treatment 1 completed NCT02036970
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT treatment 2 completed NCT03183570
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT No drug interventions diagnostic 0 recruiting NCT03641742
Families-At-risk for Interstitial Lung Disease Study No drug interventions Not Available Not Available completed NCT00957242
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis treatment 3 terminated NCT05912049
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects No drug interventions treatment 1 recruiting NCT02772549
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay No drug interventions Not Available Not Available active_not_recruiting NCT03074149
Investigating Idiopathic Pulmonary Fibrosis in Greece No drug interventions Not Available Not Available completed NCT04326036
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection No drug interventions treatment 0 enrolling_by_invitation NCT02085018
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT05195918
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients treatment 1 recruiting NCT05042219
Effects of Pulmonary Diseases and Their Treatment on Cardiac Function No drug interventions Not Available Not Available recruiting NCT04614441
NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib No drug interventions Not Available Not Available active_not_recruiting NCT00373841
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions Not Available Not Available recruiting NCT01088217
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions Not Available Not Available recruiting NCT04803617
Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease No drug interventions Not Available Not Available completed NCT03800017
Skeletal Muscle Function in Interstitial Lung Disease No drug interventions basic_science Not Available not_yet_recruiting NCT01714934
The Role of Gastric Content Microaspirations in the Pathogenesis of Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available unknown_status NCT04494334
Development of Airway Absorption Sampling Methods No drug interventions Not Available Not Available withdrawn NCT01504334
Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF) treatment 2 unknown_status NCT02827734
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) No drug interventions Not Available Not Available unknown_status NCT03710824
Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib Not Available Not Available completed NCT04429516
Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough treatment 3 completed NCT00287716
Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis treatment 3 completed NCT02951416
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank No drug interventions Not Available Not Available active_not_recruiting NCT03901196
Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy) No drug interventions Not Available Not Available completed NCT05951296
A Study to Investigate Leramistat in Patients With IPF No drug interventions treatment 2 recruiting NCT04419558
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 terminated NCT00047658
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT03457935
Detection of Early Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available active_not_recruiting NCT06135363
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects No drug interventions treatment 1 completed NCT02485886
68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis No drug interventions diagnostic 0 unknown_status NCT01817686
Study of Default Options in Advance Directives No drug interventions health_services_research Not Available completed NCT01725139
A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 1 completed NCT05060822
Phase ll Study of HEC585 in Patients With IPF treatment 2 recruiting NCT04533022
Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF No drug interventions treatment 2 completed NCT02607722
All-Case Surveillance of Ofev in Patients With IPF in Japan Not Available Not Available completed NCT03104322
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis No drug interventions other Not Available completed NCT06230822
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 1 recruiting NCT03830125
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects treatment 1 completed NCT05537025
Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 / 2 recruiting NCT06521125
Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available not_yet_recruiting NCT02848625
Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available unknown_status NCT03979430
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study No drug interventions prevention Not Available completed NCT04257630
Coping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPD No drug interventions Not Available Not Available unknown_status NCT03949530
A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis No drug interventions other 1 terminated NCT02437448
Breath Analysis in Lung Fibrosis No drug interventions Not Available Not Available completed NCT03222648
Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT02445157
Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT03591926
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment 2 withdrawn NCT03078426
Lung MRI in the Management of Idiopathic Pulmonary Fibrosis No drug interventions diagnostic Not Available completed NCT04030026
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough treatment 2 completed NCT05032066
A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis treatment 2 active_not_recruiting NCT01890265
Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT00637065
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study treatment 4 unknown_status NCT05359965
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF No drug interventions treatment Not Available recruiting NCT02739165
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis treatment 3 completed NCT04481074
Inspiratory Muscle Training in Patients With Interstitial Lung Disease No drug interventions other Not Available completed NCT04968574
A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT02759120
CleanUP IPF for the Pulmonary Trials Cooperative treatment 3 terminated NCT05321420
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 active_not_recruiting NCT04300920
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial treatment 3 active_not_recruiting NCT04708782
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis treatment 3 recruiting NCT01362231
A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis basic_science 1 completed NCT05383131
To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers treatment 1 completed NCT00903331
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study treatment 2 completed NCT03500731
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure treatment 1 / 2 recruiting NCT03047031
Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis Not Available Not Available completed NCT01777373
Conducting Airways in Lung Fibrosis (VACFI) No drug interventions Not Available Not Available completed NCT02550873
A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT04263727
A Study of Patients With Chronic Disease No drug interventions Not Available Not Available recruiting NCT05134727
Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants No drug interventions treatment 1 completed NCT03747627
BPF Genetics of ILD Study No drug interventions Not Available Not Available active_not_recruiting NCT03411876
Effects of Oxymizer Pendant Cannula Versus Conventional Nasal Cannula During Endurance Shuttle Walk Tests in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT06241560
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood treatment 2 not_yet_recruiting NCT05028894
23andMe IPF Research Study No drug interventions Not Available Not Available active_not_recruiting NCT04430491
To Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease No drug interventions Not Available Not Available completed NCT04197791
Effect of Core Stabilization Exercises and Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis No drug interventions supportive_care Not Available unknown_status NCT05863091
Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd. No drug interventions other Not Available recruiting NCT03142191
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis treatment 2 terminated NCT02803580
IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT04316780
Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes No drug interventions Not Available Not Available completed NCT02036580
D2212C00002 J-Phase II Study treatment 2 completed NCT03069989
Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging No drug interventions treatment 1 terminated NCT02600689
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT05185089
Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment 2 completed NCT03274544
Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) No drug interventions treatment Not Available terminated NCT01385644
A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment 1 completed NCT04362644
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis No drug interventions diagnostic 1 recruiting NCT05817240
A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects other 1 completed NCT02707640
A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT04986540
A Trial of SHR - 1906 in Healthy Subjects No drug interventions treatment 1 completed NCT02630940
Exhaled Breath Condensate Biomarkers and Cough in IPF No drug interventions Not Available Not Available completed NCT03538301
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF No drug interventions treatment 2 completed NCT03258801
Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available withdrawn NCT02871401
A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF) treatment 1 completed NCT01262001
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis treatment 2 completed NCT04318704
Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough treatment 2 completed NCT06049004
Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients No drug interventions Not Available Not Available not_yet_recruiting NCT06027372
Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT05313672
Inspiratory Effort and Respiratory Mechanics in Spontaneously Breathing Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Matched Control Study No drug interventions Not Available Not Available active_not_recruiting NCT02478268
Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis No drug interventions diagnostic 1 completed NCT01382368
Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients treatment 4 unknown_status NCT04016168
Idiopathic Pulmonary Fibrosis and Serum Bank No drug interventions Not Available Not Available completed NCT02551068
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib No drug interventions treatment Not Available recruiting NCT01524068
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations treatment 2 withdrawn NCT02989168
Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest supportive_care 2 terminated NCT01982968
Treatment of IPF With Laparoscopic Anti-Reflux Surgery No drug interventions treatment Not Available completed NCT03422068
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. treatment 1 completed NCT00518310
Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available unknown_status NCT03813810
Impact of Air Pollution on Chronic Respiratory Diseases No drug interventions Not Available Not Available unknown_status NCT03692481
Evolution of Lung 18FDG Uptake in Patients With Idiopathic Pulmonary Fibrosis and Receiving Pirfenidone No drug interventions other Not Available unknown_status NCT03120481
Controls for Respiratory Diseases No drug interventions Not Available Not Available recruiting NCT04233814
Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects other 1 completed NCT06200714
A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib No drug interventions Not Available Not Available recruiting NCT02267655
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF treatment 1 completed NCT05428150
Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers treatment 1 completed NCT05513950
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF No drug interventions treatment 1 completed NCT00080223
Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis other 2 completed NCT01874223
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF No drug interventions Not Available Not Available completed NCT05755308
Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis No drug interventions treatment Not Available not_yet_recruiting NCT04896138
University of Virginia Natural History Study No drug interventions Not Available Not Available enrolling_by_invitation NCT00662038
Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 3 completed NCT01203943
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) treatment 2 terminated